2020 Maternal Cell Contamination (MCC) and sexing

Scheme description
Molecular DNA sexing and determination of level of maternal cell contamination.
Disorders/Gene target(s)
X-linked disorders
SRY gene
Clinical cases
Three
Testing/analysis
Molecular DNA sexing and determination of level of maternal cell contamination.
Sample type
DNA in TE buffer
Techniques
Any methodology.
Assessment
Submit a clinical report to include:
• Determining levels of MCC
• Interpretation of the result
• Clerical accuracy
Performance criteria are applied.
Eligibility
All laboratories worldwide.
Languages
English
ISO17043 Accredited EQA
Yes
EQA timeline
Sample dispatchJune 2020
Testing period12 weeks
Assessment resultsOctober 2020
Final Summary reportDecember 2020
Other information
Submit levels of MCC and details of informative markers in MCC form.
If you wish to participate only in the MCC or sexing aspect of this EQA then please contact GenQA.
Fee
£375.00
GenQA code
2020MCC
« Return to EQA scheme list
Go to top